Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation?

Lawson, William; Hui, John C.K.; Zheng, Zheng Sheng; Burger, Lynn; Li, Jiang; Lillis, Oneida; Soroff, Harry S.; Cohn, Peter F.

doi:10.1016/s0002-9149(96)00142-7

Cited by 44 publications

(18 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Its use has been documented for more than four decades, but its use in the treatment of heart failure is incipient. Numerous small clinical studies of patients with stable chronic angina pectoris have shown improved cardiac perfusion imaging (2,(8)(9)(10)(11)(12)(13), reduction of angina class (2,9,10,12,13), increases in exercise tolerance (2,(8)(9)(10)(11), decreased use of nitroglycerine (10,12,13) and increased time to ST segment depression on stress testing with the use of EECP (2,8). Some of these studies have shown a sustained improvement for as long as five years after treatment (13).…”

Section: Eecp In Anginamentioning

confidence: 99%

The role of enhanced external counterpulsation in the treatment of angina and heart failure

Arora¹,

Shah²

2007

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Section: Eecp In Anginamentioning

confidence: 99%

The role of enhanced external counterpulsation in the treatment of angina and heart failure

Arora¹,

Shah²

2007

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…Finding that a patent vessel is required for achieving reliable benefits from EECP supports the hypothesis that development of collaterals is one mechanism by which such patients experience improved myocardial perfusion and clinical benefit. 28 Another study evaluated radionuclide perfusion treadmill stress testing in 175 patients refractory to medical therapy and ineligible for further revascularization procedures. Results showed 85% of patients reporting an improvement by at least one CCS angina class and 15% with improvement by two or more CCS angina classes following EECP.…”

Section: Clinical Outcomesmentioning

confidence: 99%

An update on enhanced external counterpulsation

2005

View full text Add to dashboard Cite

SummaryThe development of advanced revascularization techniques has resulted in the growth of a subset of patients with coronary artery disease who are nonrevascularizable and are considered to have refractory angina. Enhanced external counterpulsation (EECP) has been developed for the management of these patients with chronic, refractory disease. Evidence has shown that through improvement of vascular endothelial function and recruitment of collateral vessels, EECP provides many clinical benefits. These patients experience sustained decreases in angina, improvement in exercise time, improved myocardial perfusion, and enhanced quality of life. Furthermore, EECP appears to be safe and effective in the treatment of angina in patients with impaired systolic function and has similar potential in patients with congestive heart failure.

show abstract

“…3). 7 More extensive disease responded less well. This supported the idea that an artery needed to be open in order to transmit the pressure.…”

Section: Effectiveness Of Enhanced External Counterpulsationmentioning

confidence: 99%

Current use of enhanced external counterpulsation and patient selection

Lawson

2002

Clin Cardiol

Self Cite

View full text Add to dashboard Cite

Summary:Most patients who receive enhanced external counterpulsation (EECP) have symptomatic coronary artery disease. These patients have either responded poorly to pharmacologic therapy or are poor candidates for revascularization procedures. Such patients receive a variety of consistent benefits from EECP treatment. As more is learned about EECP, patients once excluded from early clinical trials are now able to take advantage of EECP. Nevertheless, EECP is not suitable for some patients. It has a favorable adverse event profile for most patients undergoing the treatment. Medicare reimbursement coverage limitations remain an obstacle to having a broad cross-section of patients benefit from EECP.

show abstract

Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation?

Cited by 44 publications

References 6 publications

The role of enhanced external counterpulsation in the treatment of angina and heart failure

The role of enhanced external counterpulsation in the treatment of angina and heart failure

An update on enhanced external counterpulsation

Current use of enhanced external counterpulsation and patient selection

Contact Info

Product

Resources

About